The Frequencies distribution of CYP3A5 rs776746 and ABCB1 rs1045642 polymorphisms in the west Algerian population and relationships with pharmacogenetics
- PMID: 38962329
- PMCID: PMC11217850
- DOI: 10.4314/ahs.v24i1.36
The Frequencies distribution of CYP3A5 rs776746 and ABCB1 rs1045642 polymorphisms in the west Algerian population and relationships with pharmacogenetics
Abstract
Introduction: Pharmacogenetic markers, such as the ATP Binding Cassette (ABCB1) and cytochrome P450 (CYP) 3A5 enzymes, play a crucial role in personalized medicine by influencing drug efficacy and toxicity based on individuals' or populations' genetic variations.This study aims to investigate the genetic polymorphisms of CYP3A5 (rs776746) and ABCB1 (rs1045642) in the West Algerian population and compare the genotypes and allelic distributions with those of various ethnic groups.
Methods: The study involved 472 unrelated healthy subjects from the Western Algerian population. DNA genotyping was performed using TaqMan allelic discrimination assay. The variants in our population were compared to those in other ethnic groups available in the 1000 Genomes Project. Genotype and allele frequencies were calculated using the chi-square test and the Hardy-Weinberg equilibrium (HWE).
Results: The minor allele frequencies were found to be 0.21 for CYP3A5 6986A and 0.34 for ABCB1 3435T. These frequencies were similar to those observed in North African populations, while notable differences were observed in comparison to certain Caucasian and African populations.
Conclusion: The difference in the allelic and genotypic distribution of these polymorphisms emphasize the need for dose adjustments in drugs metabolized by CYP3A5 and transported by ABCB1 to optimize treatments outcomes.
Keywords: ABCB1; CYP3A5; genetic polymorphism; pharmacogenetics; west Algeria.
© 2024 Ammour A et al.
Similar articles
-
Influence of genetic polymorphisms on imatinib concentration and therapeutic response in patients with chronic-phase chronic myeloid leukemia.Int Immunopharmacol. 2024 May 30;133:112090. doi: 10.1016/j.intimp.2024.112090. Epub 2024 Apr 18. Int Immunopharmacol. 2024. PMID: 38640718
-
Association of CYP3A4-392A/G, CYP3A5-6986A/G, and ABCB1-3435C/T Polymorphisms with Tacrolimus Dose, Serum Concentration, and Biochemical Parameters in Mexican Patients with Kidney Transplant.Genes (Basel). 2024 Apr 16;15(4):497. doi: 10.3390/genes15040497. Genes (Basel). 2024. PMID: 38674430 Free PMC article.
-
Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.Clin Pharmacokinet. 2010 Mar;49(3):141-75. doi: 10.2165/11317350-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20170205 Review.
-
Bleeding Events Associated with Rivaroxaban Therapy in Naive Patients with Nonvalvular Atrial Fibrillation: A Longitudinal Study from a Genetic Perspective with INR Follow-Up.Medicina (Kaunas). 2024 Oct 18;60(10):1712. doi: 10.3390/medicina60101712. Medicina (Kaunas). 2024. PMID: 39459499 Free PMC article.
-
Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.Clin Pharmacokinet. 2010 Apr;49(4):207-21. doi: 10.2165/11317550-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20214406 Review.
Cited by
-
The effect of CYP3A4, CYP3A5 and MDR1 (ABCB1) single nucleotide polymorphisms on the pharmacokinetics of cyclosporine in Algerian stable renal transplant recipients.Mol Biol Rep. 2025 Jul 25;52(1):756. doi: 10.1007/s11033-025-10862-z. Mol Biol Rep. 2025. PMID: 40711648
References
-
- Niemi M. Transporter Pharmacogenetics and Statin Toxicity. Clinical Pharmacology & Therapeutics. 2010;87(1):130–133. PubMed. - PubMed
-
- Turiján-Espinoza E, Ruíz-Rodríguez VM, Uresti-Rivera EE, Martínez-Leija E, Zermeño-Nava J de J, Guel-Pañola A, et al. Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients. Cancer Chemother Pharmacol. 2021 juin;87(6):843–853. PubMed. - PubMed
-
- AL-Eitan LN, Al-Maqableh HW, Mohammad NN, Khair Hakooz NM, Dajani RB. Genetic Analysis of Pharmacogenomic VIP Variants of ABCB1, VDR and TPMT Genes in an Ethnically Isolated Population from the North Caucasus Living in Jordan. CDM. 2020 juin 25;21(4):307–317. PubMed. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources